Literature DB >> 10858669

Expression of multiple plasma membrane Ca(2+)-ATPases in rat pancreatic islet cells.

A Kamagate1, A Herchuelz, A Bollen, F Van Eylen.   

Abstract

When stimulated by glucose, the pancreatic beta-cell displays large oscillations of intracellular free Ca2+ concentration ([Ca2+]i). To control [Ca2+]i, the beta-cell must be equipped with potent mechanisms for Ca2+ extrusion. We studied the expression of the plasma membrane Ca(2+)-ATPases (PMCA) in three insulin secreting preparations (a pure beta-cell preparation, RINm5F cells and pancreatic islet cells), using reverse-transcribed PCR, RNase protection assay and Western blotting. The four main isoforms, PMCA1, PMCA2, PMCA3 and PMCA4 were expressed in the three preparations. Six alternative splice mRNA variants, characterized at splice sites A, B and C were detected in the three preparations (rPMCA1xb, 2yb, 2wb, 3za, 3zc, 4xb), plus two additional variants in pancreatic islet cells (PMCA4za, 1xkb). The latter variant corresponded to a novel variant of rat PMCA1 gene lacking the exon coding for the 10th transmembrane segment, at splice site B. At the mRNA and protein level, five variants predominated (1xb, 2wb, 3za, 3zc, 4xb), whilst one additional isoform (4za), predominated at the protein level only. This provides the first evidence for the presence of PMCA2 and PMCA3 isoforms at the protein level in non-neuronal tissue. Hence, the pancreatic beta-cell is equipped with multiple PMCA isoforms with possible differential regulation, providing a full range of PMCAs for [Ca2+]i regulation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10858669     DOI: 10.1054/ceca.2000.0116

Source DB:  PubMed          Journal:  Cell Calcium        ISSN: 0143-4160            Impact factor:   6.817


  8 in total

Review 1.  Plasma membrane Ca2+ ATPases as dynamic regulators of cellular calcium handling.

Authors:  Emanuel E Strehler; Ariel J Caride; Adelaida G Filoteo; Yuning Xiong; John T Penniston; Agnes Enyedi
Journal:  Ann N Y Acad Sci       Date:  2007-03       Impact factor: 5.691

2.  Plasma membrane calcium-ATPase isoform four distribution changes during corneal epithelial wound healing.

Authors:  Ernest F Talarico
Journal:  Mol Vis       Date:  2010-11-02       Impact factor: 2.367

3.  Characterization of the Molecular Mechanisms Underlying Glucose Stimulated Insulin Secretion from Isolated Pancreatic β-cells Using Post-translational Modification Specific Proteomics (PTMomics).

Authors:  Taewook Kang; Pia Jensen; Honggang Huang; Gitte Lund Christensen; Nils Billestrup; Martin R Larsen
Journal:  Mol Cell Proteomics       Date:  2017-11-07       Impact factor: 5.911

4.  Heterozygous inactivation of plasma membrane Ca(2+)-ATPase in mice increases glucose-induced insulin release and beta cell proliferation, mass and viability.

Authors:  Nathalie Pachera; Julien Papin; Francesco P Zummo; Jacques Rahier; Jan Mast; Kira Meyerovich; Alessandra K Cardozo; André Herchuelz
Journal:  Diabetologia       Date:  2015-09-11       Impact factor: 10.122

Review 5.  Caloxins: a novel class of selective plasma membrane Ca2+ pump inhibitors obtained using biotechnology.

Authors:  Magdalena M Szewczyk; Jyoti Pande; Ashok K Grover
Journal:  Pflugers Arch       Date:  2007-10-02       Impact factor: 3.657

6.  Alternative splice variants of plasma membrane calcium-ATPases in human corneal epithelium.

Authors:  Ernest F Talarico; Nancy J Mangini
Journal:  Exp Eye Res       Date:  2007-09-05       Impact factor: 3.467

7.  NFAT1 and NFAT3 cooperate with HDAC4 during regulation of alternative splicing of PMCA isoforms in PC12 cells.

Authors:  Michalina Kosiorek; Paulina Podszywalow-Bartnicka; Ludmila Zylinska; Slawomir Pikula
Journal:  PLoS One       Date:  2014-06-06       Impact factor: 3.240

8.  Calcineurin/NFAT signaling represses genes Vamp1 and Vamp2 via PMCA-dependent mechanism during dopamine secretion by Pheochromocytoma cells.

Authors:  Michalina Kosiorek; Ludmila Zylinska; Krzysztof Zablocki; Slawomir Pikula
Journal:  PLoS One       Date:  2014-03-25       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.